loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r0_cep_2017_268___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 HISUN PHARMACEUTICAL (NANTONG) CO., LTD. Nantong City CN (1)

filter

01 Celecoxib (1)

filter

01 China (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2017-268 - Rev 01
Withdrawn by Holder
Chemical
2018-10-23
2019-09-30
2591
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-268 - Rev 01 of Hisun Pharmaceutical (nantong) Co., Ltd. Nantong City Cn

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-268 - Rev 01 of Hisun Pharmaceutical (nantong) Co., Ltd. Nantong City Cn 1

20

Hisun Pharmaceutical (nantong) Co., Ltd. Nantong City Cn, based in China, is a pharmaceutical company.

One of their significant offerings is Celecoxib, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-268 - Rev 01

This Chemical Type CEP, issued on October 23, 2018, remains in force until September 30, 2019, ensuring its reliability within the pharmaceutical industry.

Substance Number 2591 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY